Lopez-Ribot JL - Search Results

1

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.

Pierce CG, Lopez-Ribot JL. Pierce CG, et al. Expert Opin Drug Discov. 2013 Sep;8(9):1117-26. doi: 10.1517/17460441.2013.807245. Epub 2013 Jun 6. Expert Opin Drug Discov. 2013. PMID: 23738751 Free PMC article. Review.

2

Candida dubliniensis in radiation-induced oropharyngeal candidiasis.

Redding SW, Bailey CW, Lopez-Ribot JL, Kirkpatrick WR, Fothergill AW, Rinaldi MG, Patterson TF. Redding SW, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):659-62. doi: 10.1067/moe.2001.112946. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001. PMID: 11402278

3

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Ramage G, et al. Antimicrob Agents Chemother. 2001 Sep;45(9):2475-9. doi: 10.1128/AAC.45.9.2475-2479.2001. Antimicrob Agents Chemother. 2001. PMID: 11502517 Free PMC article.

4

Biofilm formation by Candida dubliniensis.

Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Ramage G, et al. J Clin Microbiol. 2001 Sep;39(9):3234-40. doi: 10.1128/JCM.39.9.3234-3240.2001. J Clin Microbiol. 2001. PMID: 11526156 Free PMC article.

5

Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.

Martínez M, López-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, Ruesga MT, Patterson TF. Martínez M, et al. J Antimicrob Chemother. 2002 Mar;49(3):515-24. doi: 10.1093/jac/49.3.515. J Antimicrob Chemother. 2002. PMID: 11864952

6

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF. Perea S, et al. Antimicrob Agents Chemother. 2002 Jun;46(6):1695-703. doi: 10.1128/AAC.46.6.1695-1703.2002. Antimicrob Agents Chemother. 2002. PMID: 12019078 Free PMC article.

7

Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.

Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL. Ramage G, et al. J Antimicrob Chemother. 2002 Jun;49(6):973-80. doi: 10.1093/jac/dkf049. J Antimicrob Chemother. 2002. PMID: 12039889

8

Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. Martinez M, et al. J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002. J Clin Microbiol. 2002. PMID: 12202543 Free PMC article.

9

The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans.

Ramage G, VandeWalle K, López-Ribot JL, Wickes BL. Ramage G, et al. FEMS Microbiol Lett. 2002 Aug 27;214(1):95-100. doi: 10.1111/j.1574-6968.2002.tb11330.x. FEMS Microbiol Lett. 2002. PMID: 12204378

10

Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.

Redding SW, Kirkpatrick WR, Saville S, Coco BJ, White W, Fothergill A, Rinaldi M, Eng T, Patterson TF, Lopez-Ribot J. Redding SW, et al. J Clin Microbiol. 2003 Feb;41(2):619-22. doi: 10.1128/JCM.41.2.619-622.2003. J Clin Microbiol. 2003. PMID: 12574256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page